You are here: Industry Insights > Astellas

News List

Astellas, Sunovion and Shield breach ABPI Code pharmatimes
December 19, 2018
The Prescription Medicines Code of Practice Authority (PMCPA) has announced that Astellas Pharmaceuticals, Sunovion Pharmaceuticals and Shield Therapeutics have all breached the Association
Astellas buys Potenza Therapeutics for up to $405m pharmaceutical-technology
December 18, 2018
Japanese pharmaceutical company Astellas Pharma has acquired US-based Potenza Therapeutics for a total consideration of up to $405m.
Astellas Acquires Potenza Therapeutics pharmafocusasia
December 17, 2018
Astellas Pharma Inc today announced that it exercised, and closed on its exclusive option to acquire Potenza Therapeutics, Inc. ("Potenza") on December 13, 2018, U.S. Eastern Time.....
Astellas Launches XOSPATA for Relapsed/Refractory AML with a FLT3 Mutation americanpharmaceuticalreview
December 12, 2018
Astellas Pharma announced that XOSPATA (gilteritinib) is now available for prescription in the United States for the treatment of adult patients who have relapsed .....
Astellas scores first US blood cancer approval with Xospata pharmaphorum
December 03, 2018
The FDA has approved Astellas’ Xospata for certain patients with acute myeloid leukaemia – the company’s first drug approved in blood cancer.
Astellas’ kidney disease drug shows promise in PhIII pharmatimes
September 27, 2018
A Phase III study assessing Astellas’ roxadustat in patients with chronic kidney disease (CKD) and anaemia who are not receiving dialysis has met its key endpoints.
Astellas announces approval of Linzess Tablets in Japan biospectrumasia
August 29, 2018
Linzess Tablets 0.25 mg were licensed from Ironwood Pharmaceuticals and have been developed and commercialized in Japan by Astellas
Astellas Appoints Senior Vice President Health Systems americanpharmaceuticalreview
August 27, 2018
Astellas announced that Shontelle Dodson, Pharm.D, has been appointed to senior vice president, Health Systems.
Astellas Appoints Latin America VP contractpharma
August 27, 2018
Rodrigo Fernandez has been promoted to vice president, Latin America, Astellas. Mr. Fernandez will be based in Northbrook and report to Percival Barretto-Ko, president, Astellas Americas......
Pfizer, Astellas Amend Research Protocols for Two Enzalutamide Trials americanpharmaceuticalreview
August 24, 2018
Pfizer and Astellas announced amendments to the protocols for two registrational Phase 3 trials, ARCHES and EMBARK, designed to evaluate the safety and efficacy of Xtandi (enzalutamide) in men with hormone-sensitive prostate cancer (HSPC).

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page